These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33347867)

  • 1. Targeting Akt-associated microRNAs for cancer therapeutics.
    Adil MS; Khulood D; Somanath PR
    Biochem Pharmacol; 2021 Jul; 189():114384. PubMed ID: 33347867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Akt-associated microRNAs.
    Xu M; Mo YY
    Cell Mol Life Sci; 2012 Nov; 69(21):3601-12. PubMed ID: 22936352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
    Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
    Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt in cancer: Mediator and more.
    Revathidevi S; Munirajan AK
    Semin Cancer Biol; 2019 Dec; 59():80-91. PubMed ID: 31173856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer.
    Taefehshokr S; Taefehshokr N; Derakhshani A; Baghbanzadeh A; Astamal RV; Safaei S; Abbasi S; Hajazimian S; Maroufi NF; Isazadeh A; Hajiasgharzadeh K; Baradaran B
    Curr Mol Med; 2022; 22(3):263-273. PubMed ID: 34238182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multifunctional Nature of the MicroRNA/AKT3 Regulatory Axis in Human Cancers.
    Yang C; Hardy P
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development of anticancer therapeutics targeting Akt.
    Morrow JK; Du-Cuny L; Chen L; Meuillet EJ; Mash EA; Powis G; Zhang S
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):146-59. PubMed ID: 21110830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer.
    Akbarzadeh M; Mihanfar A; Akbarzadeh S; Yousefi B; Majidinia M
    Life Sci; 2021 Nov; 285():119984. PubMed ID: 34592229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as therapeutic targets in chemoresistance.
    Garofalo M; Croce CM
    Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives.
    Tabnak P; Masrouri S; Geraylow KR; Zarei M; Esmailpoor ZH
    Biomed Pharmacother; 2021 Dec; 144():112309. PubMed ID: 34653761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 14. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
    Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
    Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery.
    Cheng GZ; Park S; Shu S; He L; Kong W; Zhang W; Yuan Z; Wang LH; Cheng JQ
    Curr Cancer Drug Targets; 2008 Feb; 8(1):2-6. PubMed ID: 18288938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoid display ability to target microRNAs in cancer pathogenesis.
    Singh S; Raza W; Parveen S; Meena A; Luqman S
    Biochem Pharmacol; 2021 Jul; 189():114409. PubMed ID: 33428895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.